Trial intelligence / Profile preview

RAS and RV Function in Mechanically Ventilated Patients

NCT03212690Terminated

Sponsor
GSK
Start
Jun 2018
Primary completion
Jul 2019
Countries
1
01

Overview

Single-arm trial, sponsored by GSK. Primary endpoints: Renin-angiotensin System Cascade Biomarker to Include Angiotensin (Ang) II Level, Ratio of RV to Left Ventricular (LV) End-diastolic Area (RV Size Ratio) and 6 more. Started Jun 2018; status: terminated.

Beyond the preview

Go deeper on NCT03212690.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03212690.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call